Exclusive VaccineNation interview with AELIX’s CSO, Dr. Christian Brander, on the development of HIV therapies

Exclusive VaccineNation interview with AELIX’s CSO, Dr. Christian Brander, on the development of HIV therapies
By VR | November 18, 2022

LINK TO NEWS